These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30527272)

  • 1. Investigation of peripheral complement factors across stages of psychosis.
    Laskaris L; Zalesky A; Weickert CS; Di Biase MA; Chana G; Baune BT; Bousman C; Nelson B; McGorry P; Everall I; Pantelis C; Cropley V
    Schizophr Res; 2019 Feb; 204():30-37. PubMed ID: 30527272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis.
    Cropley VL; Kittel M; Heurich M; Föcking M; Leweke FM; Pantelis C
    Brain Behav Immun; 2023 Oct; 113():136-144. PubMed ID: 37437819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement system biomarkers in first episode psychosis.
    Kopczynska M; Zelek W; Touchard S; Gaughran F; Di Forti M; Mondelli V; Murray R; O'Donovan MC; Morgan BP
    Schizophr Res; 2019 Feb; 204():16-22. PubMed ID: 29279246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of selective complement markers with schizophrenia.
    Mohd Asyraf AJ; Nour El Huda AR; Hanisah MN; Norsidah KZ; Norlelawati AT
    J Neuroimmunol; 2022 Feb; 363():577793. PubMed ID: 34990981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Genotype and Peripheral Complement Proteins in First-Episode Psychosis: Evidences From C3 and C4.
    Chen Y; Zhao Z; Lin F; Wang L; Lin Z; Yue W
    Front Genet; 2021; 12():647246. PubMed ID: 34306006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia.
    Purves-Tyson TD; Robinson K; Brown AM; Boerrigter D; Cai HQ; Weissleder C; Owens SJ; Rothmond DA; Shannon Weickert C
    Front Immunol; 2020; 11():2002. PubMed ID: 33133060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower complement C1q levels in first-episode psychosis and in schizophrenia.
    Koskuvi M; Malwade S; Gracias Lekander J; Hörbeck E; Bruno S; Holmen Larsson J; Pelanis A; Isgren A; Goulding A; Fatouros-Bergman H; Samudyata ; Schalling M; Piehl F; Erhardt S; Landen M; Cervenka S; Orhan F; Sellgren CM
    Brain Behav Immun; 2024 Mar; 117():313-319. PubMed ID: 38301948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered depth of the olfactory sulcus in ultra high-risk individuals and patients with psychotic disorders.
    Takahashi T; Wood SJ; Yung AR; Nelson B; Lin A; Yücel M; Phillips LJ; Nakamura Y; Suzuki M; Brewer WJ; Proffitt TM; McGorry PD; Velakoulis D; Pantelis C
    Schizophr Res; 2014 Mar; 153(1-3):18-24. PubMed ID: 24530137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathology and Stem Cell Mobilization in Ultra-High Risk of Psychosis and First-Episode Psychosis Patients.
    Waszczuk K; Kucharska-Mazur J; Tyburski E; Rek-Owodziń K; Plichta P; Rudkowski K; Podwalski P; Grąźlewski T; Mak M; Misiak B; Michalczyk A; Tarnowski M; Sielatycka K; Szczęśniak A; Łuczkowska K; Dołęgowska B; Budkowska M; Ratajczak MZ; Samochowiec J
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.
    García-Bueno B; Bioque M; Mac-Dowell KS; Barcones MF; Martínez-Cengotitabengoa M; Pina-Camacho L; Rodríguez-Jiménez R; Sáiz PA; Castro C; Lafuente A; Santabárbara J; González-Pinto A; Parellada M; Rubio G; García-Portilla MP; Micó JA; Bernardo M; Leza JC
    Schizophr Bull; 2014 Mar; 40(2):376-87. PubMed ID: 23486748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal complement C1q and increased odds for psychosis in adult offspring.
    Severance EG; Gressitt KL; Buka SL; Cannon TD; Yolken RH
    Schizophr Res; 2014 Oct; 159(1):14-9. PubMed ID: 25195065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosis.
    Mondelli V; Di Forti M; Morgan BP; Murray RM; Pariante CM; Dazzan P
    Brain Behav Immun; 2020 Aug; 88():913-915. PubMed ID: 31981599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-reduction in hippocampal volume is associated with higher risk of psychosis.
    Phillips LJ; Velakoulis D; Pantelis C; Wood S; Yuen HP; Yung AR; Desmond P; Brewer W; McGorry PD
    Schizophr Res; 2002 Dec; 58(2-3):145-58. PubMed ID: 12409154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration and frequency mismatch negativity shows no progressive reduction in early stages of psychosis.
    Koshiyama D; Kirihara K; Tada M; Nagai T; Koike S; Suga M; Araki T; Kasai K
    Schizophr Res; 2017 Dec; 190():32-38. PubMed ID: 28314681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum complement components in patients with trachoma.
    Sen DK; Sarin GS; Hiranandani M; Baveja UK
    Br J Ophthalmol; 1985 Sep; 69(9):707-10. PubMed ID: 3876110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
    Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
    Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
    Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement factors in newly diagnosed Nigerian schizoprenic patients and those on antipsychotic therapy.
    Idonije OB; Akinlade KS; Ihenyen O; Arinola OG
    Niger J Physiol Sci; 2012 Jun; 27(1):19-21. PubMed ID: 23235303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive impairments in individuals at ultra-high risk for psychosis: Who will really convert?
    Bang M; Kim KR; Song YY; Baek S; Lee E; An SK
    Aust N Z J Psychiatry; 2015 May; 49(5):462-70. PubMed ID: 25425742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.